SCHEMBL30476362

SCHEMBL30476362

CCc1ncccc1NC1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
NOS2 P35228 2/20 0.52
GPR119 Q8TDV5 4/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
NPC1 O15118 1/20 0.51
MAPT P10636 1/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 1/20 0.51
POLB P06746 1/20 0.49
BRD4 O60885 1/20 0.49
CCNA2 P20248 1/20 0.47
CDK2 P24941 1/20 0.47
USP30 Q70CQ3 2/20 0.46
DTYMK P23919 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
KDM4E B2RXH2 1/20 0.45
PKM P14618 1/20 0.45
NOS3 P29474 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20818548 1.00 ALDH1A1 (0.52) ALDH1A1NOS2GPR119L3MBTL1NPC1
SCHEMBL20817804 0.84 ALDH1A1 (0.54) ALDH1A1NOS2GPR119L3MBTL1NPC1
SCHEMBL30476370 0.84 ALDH1A1 (0.54) ALDH1A1NOS2GPR119L3MBTL1NPC1
SCHEMBL1198309 0.84 CCNA2 (0.55) ALDH1A1NOS2GPR119L3MBTL1NPC1
SCHEMBL27092752 0.84 POLB (0.63) ALDH1A1NOS2GPR119L3MBTL1NPC1
SCHEMBL30006703 0.84 CCNA2 (0.55) ALDH1A1NOS2GPR119L3MBTL1NPC1
SCHEMBL25229965 0.84 NOS2 (0.49) ALDH1A1NOS2L3MBTL1MAPTMEN1
SCHEMBL20818187 0.82 ALDH1A1 (0.51) ALDH1A1NOS2GPR119L3MBTL1NPC1
SCHEMBL23360307 0.82 ALDH1A1 (0.51) ALDH1A1NOS2GPR119L3MBTL1NPC1
SCHEMBL30476409 0.82 ALDH1A1 (0.51) ALDH1A1NOS2GPR119L3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12435078-B2 Pyridazinones and methods of use thereof GFB (ABC), LLC (US) 2025-10-07 US disclosed
US-20230203028-A1 PYRIDAZINONES AND METHODS OF USE THEREOF GFB (ABC), LLC 2023-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203028-A1 PYRIDAZINONES AND METHODS OF USE THEREOF PDXK, ATP6V1B1, REN ALDH1A1 649/4885NOS2 2464/4885GPR119 846/4885
US-12435078-B2 Pyridazinones and methods of use thereof PDXK, ATP6V1B1, REN ALDH1A1 649/4885NOS2 2464/4885GPR119 846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.